An ecofriendly green liquid chromatographic method for simultaneous determination of nicotinamide and clindamycin phosphate in pharmaceutical gel for acne treatment

摘要

Abstract A new green micellar liquid chromatographic method was developed and validated for the quantitative estimation of nicotinamide (NICO) and clindamycin phosphate (CLD) in bulk and pharmaceutical gel formulation. The analytes are well resolved in less than 6.0 minutes using micellar mobile phase consisting of 0.10M sodium dodecyl sulfate (SDS), 0.3% triethylamine, and 10% 2-propanol in 0.02M orthophosphoric acid at pH 3.0, running through an Eclipse XDB-C 8 column (150?mm × 4.6?mm, 5?μm particle size) with flow rate 1.0?mL/min. The effluent was monitored with diode array detection at 210?nm. The retention times of NICO and CLD were 3.8 minutes and 5.6 minutes, respectively. The method was validated according to the International Conference on Harmonisation (ICH) guidelines in terms of linearity, limit of detection, limit of quantification, accuracy, precision, robustness, and specificity to prove its reliability. Linear correlation was achieved by plotting the peak area of each drug against its concentration. It was found to be rectilinear in the ranges of 1.0–40.0?μg/mL and 0.5–15.0?μg/mL with limits of detection of 0.06?μg/mL and 0.03?μg/mL and limits of quantification of 0.19?μg/mL and 0.09?μg/mL for NICO and CLD, respectively. The method was successfully implemented for the simultaneous determination of the analytes in their bulk powder and combined gel formulation with high % recoveries. The ease of sample treatment facilitates and greatly expedites the treatment with reduced cost and improved accuracy of the procedure. Graphical abstract Display Omitted Highlights ? A green micellar liquid chromatographic method was adopted for assay of NICO and CLD. ? The method was successfully extended to quantify both drugs in a coformulated gel. ? The method was validated according to ICH Q2R1 Guidelines.